ARCHIVES

FDA Ponders Standards For “Retrospective Prospective” Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

Government Offers Two Approval Standards For Assays: CLIA, FDA

January 30, 2009

Translucent Walls, Modern Classics Create “Corporate Feel” In Office Suite Occupied By Wife of MD Anderson President DePinho

May 24, 2013

NCAB Subcommittee Approves Compromise On Changes In Organ Site Program

April 9, 1982

AACI Committee Makes Case For Clinical Research In Centers; Cancer Control, Group Funds Eyed

December 8, 1978

AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI.

December 14, 2001